Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

CDMO Celonic to beef up cell and gene therapy work at up-and-coming Novartis hub

Like many CDMOs these days, Switzerland’s Celonic aims to make a big splash in cell and gene therapy—and it’s picked up space at an emerging Novartis life sciences hub to take that work to the next level.  Celonic sewed up a long-term lease for production and office space in the WST-222 building of Novartis’ hub-to-be in Stein, Switzerland, […]

AbbVie sells biologics plant to Pharmaron, fueling the China company’s cell and gene therapy ambitions

Roughly half a year after closing its $63 billion megamerger with Allergan, AbbVie is letting go of the drugmaker’s Liverpool, England biologics plant.  AbbVie agreed to sell off the biomanufacturing plant to China-based Pharmaron for $118.7 million in cash. The move comes shortly after Pharmaron bought out Absorption Systems in the U.S., paving the way for a cell and gene […]

Look for Eli Lilly’s Verzenio to hit $4.6B, thanks to early breast cancer win: analyst

In the kinase inhibitor class of breast cancer drugs, Pfizer’s Ibrance has held a strong lead in market share—and sales—over Eli Lilly’s Verzenio. But on the heels of Verzenio’s strong showing in HR+/HER2- early breast cancer—and Ibrance’s miss—one influential analyst figures the Lilly drug will quickly pick up steam. The upshot? About $4.6 billion in sales at the peak, significantly more than most pharma watchers […]

Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court

In its high-profile patent feud with the U.S. government over HIV prevention medicines, Gilead Sciences has suffered its second consecutive loss.  Following a similar decision earlier this month, the U.S. Patent & Trademark Office’s Patent Trial and Appeal Board decided not to strike up inter partes reviews (IPR) of patents held by the U.S. government. Gilead had challenged the patents […]

With lawsuits looming, U.S. OxyContin maker considers bankruptcy

The company that has made billions selling the prescription painkiller OxyContin said Wednesday that it is considering legal options including bankruptcy, a move that could upend hundreds of lawsuits claiming it had a major role in causing the U.S. opioid drug crisis. “As the company has stated, it is exploring and preparing for any number […]

Tobacco firm’s payout in $15B lawsuit on hold after court ruling

One of the cigarette makers that lost an appeal of a landmark $15-billion class action lawsuit has obtained a temporary reprieve from compensating 100,000 Quebec smokers after securing creditor protection in an Ontario court. A judge granted JTI-Macdonald Corp. creditor protection last Friday afternoon, the latest development in a legal battle that has gone on for […]

Stephen Hawking’s ex-nurse barred from practising after failing to give him ‘appropriate’ care

British regulators have barred Stephen Hawking’s former nurse from practising after finding she failed to provide appropriate care to the late physicist. The Nursing and Midwifery Council censured Patricia Dowdy, 61, who faced multiple misconduct charges, including financial misconduct, dishonesty, not providing appropriate care, failing to co-operate with the council and not having the correct […]